Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy
Pathogens · 2024
DOI: 10.3390/pathogens13110958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Lai Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100089, China. Hauptthemen laut MEDLINE: Methylene Blue, Antiviral Agents, SARS-CoV-2, Virus Replication. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the NSFC-MFST project (China-Mongolia), the Foundation of State Key Laboratory of Pathogen and Biosecurity, NSFC-MFST project (China–Mongolia).
Abstract (Originalsprache)
Studies have demonstrated that methylene blue exhibits significant antiviral activity against SARS-CoV-2 or related coronaviruses at the cellular level, suggesting its potential as an anti-SARS-CoV-2 drug. Herein, we report that methylene blue does not exhibit noticeable antiviral activity in a lethal model involving SARS-CoV-2-related pangolin coronavirus GX_P2V (short_3UTR) infection in CAG-hACE2 transgenic mice. We employed plaque reduction assays and cell infection experiments to compare the extracellular virucidal activity of the compound and its ability to inhibit viral replication in cells to those of nirmatrelvir. Methylene blue demonstrated strong virucidal activity but did not inhibit viral replication in cells. The control compound nirmatrelvir lacked virucidal activity but exhibited strong abilities to inhibit viral replication. The virucidal activity of methylene blue was further tested in mouse plasma. Incubation in mouse plasma increased the virucidal EC50 value of methylene blue, indicating that mouse plasma can affect the stability of the compound, although mouse plasma has some extent of natural virucidal activity. These findings elucidate why methylene blue lacks antiviral efficacy in vivo and provide insights for the development of antiviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100089, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
- The Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China.
- Institute of Infectious Diseases Medicine, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
- State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing 210093, China.
ORCID-Profile: Lai Wei, Erguang Li, Huahao Fan, Lihua Song
Förderung
- the NSFC-MFST project (China-Mongolia)
- the Foundation of State Key Laboratory of Pathogen and Biosecurity
- NSFC-MFST project (China–Mongolia)
- Foundation of State Key Laboratory of Pathogen and Biosecurity
Zitieren
APA
Wei, L., Ma, Y., Ren, Y., Lu, S., Xiao, X., Luo, S., An, X., Li, E., Fan, H., & Song, L. (2024). Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy. Pathogens. https://doi.org/10.3390/pathogens13110958
Vancouver
Wei L, Ma Y, Ren Y, Lu S, Xiao X, Luo S, et al. Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy. Pathogens. 2024. doi:10.3390/pathogens13110958
BibTeX
@article{Wei2024,
author = {Wei, Lai and Ma, Yuezhen and Ren, Yuhao and Lu, Shanshan and Xiao, Xiumei and Luo, Shengdong and An, Xiaoping and Li, Erguang and Fan, Huahao and Song, Lihua},
title = {Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13110958}
}
EUVIMED